Osaic Holdings
CBAY

Osaic Holdings’s Cymabay Therapeutics CBAY Stock Holding History

Osaic Holdings’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,597
Closed -$463K – 7473
2023
Q4 		$463K Buy
19,597
+15,436
+371% +$275K ﹤0.01% 3232
2023
Q3 		$62K Sell
4,161
-2,633
-39% -$34.9K ﹤0.01% 4835
2023
Q2 		$73.8K Buy
6,794
+544
+9% +$5.07K ﹤0.01% 4688
2023
Q1 		$56.3K Hold
6,250
– – ﹤0.01% 4865
2022
Q4 		$39K Hold
6,250
– – ﹤0.01% 5117
2022
Q3 		$22K Hold
6,250
– – ﹤0.01% 5528
2022
Q2 		$17K Hold
6,250
– – ﹤0.01% 5742
2022
Q1 		$11M Hold
6,250
– – 0.02% 705
2021
Q4 		$23K Hold
6,250
– – ﹤0.01% 5703
2021
Q3 		$23K Buy
+6,250
New +$24.6K ﹤0.01% 5690
2021
Q2 		– Sell
-1,000
Closed -$5K – 7180
2021
Q1 		$5K Buy
+1,000
New +$5.38K ﹤0.01% 6196
2020
Q4 		– Sell
-2,000
Closed -$14K – 6642
2020
Q3 		$14K Buy
+2,000
New +$10.7K ﹤0.01% 5124

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's CBAY Position: Q1 2024 in Review

Osaic Holdings sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 19,597 shares — an estimated $463K sold.

Osaic Holdings first reported a position in CBAY in Q3 2020 and held it in 12 quarters. The position peaked at $11M in Q1 2022. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Osaic Holdings reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 19,597 Cymabay Therapeutics shares in Q1 2024, an estimated $463K.
  • Osaic Holdings first reported a position in Cymabay Therapeutics in Q3 2020 and held it in 12 quarters.
  • Osaic Holdings's Cymabay Therapeutics position peaked at $11M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.